This page shows the publications co-authored by Sengwee Darren Toh and Noelle Cocoros.
The Certainty Framework for Assessing Real-World Data in Studies of Medical Product Safety and Effectiveness. Clin Pharmacol Ther. 2021 05; 109(5):1189-1196.
Identification of potential drug name confusion errors in the Sentinel System. Pharmacoepidemiol Drug Saf. 2019 10; 28(10):1405-1410.
Outpatient influenza antivirals in a distributed data network for influenza surveillance. Influenza Other Respir Viruses. 2018 11; 12(6):804-807.
Evaluating confounding control in estimations of influenza antiviral effectiveness in electronic health plan data. Am J Epidemiol. 2022 Feb 02.
Validation of diagnosis codes to identify hospitalized COVID-19 patients in health care claims data. Pharmacoepidemiol Drug Saf. 2022 04; 31(4):476-480.
Who gets treated for influenza: A surveillance study from the US Food and Drug Administration's Sentinel System. Infect Control Hosp Epidemiol. 2021 Aug 05; 1-7.
A COVID-19-ready public health surveillance system: The Food and Drug Administration's Sentinel System. Pharmacoepidemiol Drug Saf. 2021 07; 30(7):827-837.
Leveraging the Capabilities of the FDA's Sentinel System To Improve Kidney Care. J Am Soc Nephrol. 2020 11; 31(11):2506-2516.
Risk of Psychiatric Adverse Events Among Montelukast Users. J Allergy Clin Immunol Pract. 2021 01; 9(1):385-393.e12.
Evaluation of the US Food and Drug Administration Sentinel Analysis Tools Using a Comparator with a Different Indication: Comparing the Rates of Gastrointestinal Bleeding in Warfarin and Statin Users. Pharmaceut Med. 2019 02; 33(1):29-43.
Development and application of two semi-automated tools for targeted medical product surveillance in a distributed data network. Curr Epidemiol Rep. 2017 Dec; 4(4):298-306.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.